碳离子放疗前列腺癌后急性毒性与生活质量临床因素初探
结果显示碳离子放疗后生活质量总体良好,无急慢性胃肠道毒性,IPSS≥8使急性1-2级泌尿生殖毒性风险增加5.3倍,TURP史预测泌尿生活质量下降。
要点
- 碳离子放疗后患者生活质量总体良好,无急慢性胃肠道毒性发生。
- IPSS≥8使急性1-2级泌尿生殖毒性风险增加5.3倍。
- TURP史预测泌尿生活质量下降,去势状态与性生活质量相关。
核心结论
- 前列腺癌患者碳离子放疗后生活质量良好。
- IPSS≥8是急性泌尿生殖毒性的危险因素。
- TURP史预测泌尿生活质量下降,年龄与肠道生活质量相关,去势状态与性生活质量相关。
研究设计与样本
- 所有患者接受碳离子放疗,采用EPIC-26中文版在基线和放疗后5个时间点评估生活质量。
- 采用Logistic回归分析急性泌尿生殖毒性和相对生活质量相关的临床因素。
主要发现
- 泌尿失禁、肠道和性生活质量评分在2年随访中保持稳定。
- 急性1级和2级泌尿生殖毒性发生率分别为20.3%和10.9%,晚期1级和2级分别为3.1%和1.6%。
- 无急性和晚期胃肠道毒性发生。
- TURP是泌尿相关生活质量下降的危险因素,年龄影响肠道相关生活质量,去势状态是性生活质量的重要危险因素。
关键数值与推荐
- 急性1级泌尿生殖毒性发生率20.3%,2级10.9%。
- 晚期1级泌尿生殖毒性发生率3.1%,2级1.6%。
- IPSS≥8使1-2级急性泌尿生殖毒性风险增加5.3倍。
临床怎么用
- 碳离子放疗可用于局限期前列腺癌,需关注基线IPSS≥8、TURP史、年龄和去势状态对毒性和生活质量的影响。
- 对IPSS≥8患者应加强急性泌尿生殖毒性的监测与预防。
- 对有TURP史患者需关注泌尿生活质量下降,去势状态患者需关注性生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess toxicity and quality-of-life (QOL) after carbon ion radiotherapy (CIRT) at the Shanghai Proton and Heavy Ion Center (SPHIC) and identify clinical factors that correlate with urinary, bowel and sexual function. METHODS: Sixty-four patients with localized prostate cancer admitted from July 2015 to January 2018 underwent CIRT. At baseline and 5 time-points after radiotherapy, we assessed patients' QOL using the 26-item edition of the Expanded Prostate Cancer Index-Composite (EPIC-26) Chinese version. Logistic regression was performed to identify clinical factors associated with acute genitourinary (GU) toxicity and relative QOL. RESULTS: By the end of CIRT, urinary irritation/obstruction temporarily declined (- 7.92 ± 1.76, p < .001). For urinary incontinence, bowel and sexual QOL, the scores remained stable at 2-year follow-up. The occurrences of acute Grade 1 and 2 GU toxicity were 20.3 and 10.9%, respectively, and of late Grade 1 and 2 GU toxicity were 3.1 and 1.6%, respectively. No acute or late gastrointestinal (GI) toxicity occurred. Transurethral resection of the prostate (TURP) was a risk factor that predicted a decline in urinary related QOL, and age made a difference to bowel-related QOL. For sexual QOL, castration status was a remarkable risk factor. An international prostate symptom score (IPSS) ≥8 increased the risk of Grade 1-2 acute GU toxicity 5.3-fold. CONCLUSION: Patients with prostate cancer had favorable QOL after CIRT. IPSS ≥8 was a risk factor to acute GU toxicity, and TURP predicted a decline in urinary QOL. Age was related to bowel QOL, and castration status was associated with sexual QOL. TRIAL REGISTRATION: Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer, NCT02739659 . Registered April 15, 2016.
引用
- Zhang Y, Li P, Yu Q, et al. Preliminary exploration of clinical factors affecting acute toxicity and quality of life after carbon ion therapy for prostate cancer. Radiat Oncol. 2019. PMID: 31164172. doi:10.1186/s13014-019-1303-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。